Similarly, cancer cell apoptosis decreased (Figure 3B; Figure S3A) while cell proliferation (Figure 3C), cell invasion (Figure 3D; Figure S3B), and drug resistance for EPI (Figure 3E) increased with GPER activation in E2‐treated CAFs. The gene discussed is GPER1; the disease is cancer.